Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check31 days agoNo Change Detected
- Check46 days agoChange DetectedThe study has expanded to include 9 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check59 days agoChange DetectedDifference0.2%
- Check64 days agoChange DetectedDifference0.2%
Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.